Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Says R&D Efficiency Is Above Average, Rx Prices Not Tied To Research

Executive Summary

The increasing cost of drug development will force companies to compete based on the efficiency of their R&D programs, Merck CEO Raymond Gilmartin suggested during a Nov. 30 Tufts Center for the Study of Drug Development briefing in Philadelphia

You may also be interested in...



Rx Prices Reflect “Anticipated Income,” Not R&D Costs, Pfizer CEO Says

Pharmaceutical pricing decisions are based on "anticipated income" rather than achieving a return on R&D costs, Pfizer CEO Hank McKinnell writes in his recently published book A Call To Action: Taking Back Healthcare for Future Generations

Rx Prices Reflect “Anticipated Income,” Not R&D Costs, Pfizer CEO Says

Pharmaceutical pricing decisions are based on "anticipated income" rather than achieving a return on R&D costs, Pfizer CEO Hank McKinnell writes in his recently published book A Call To Action: Taking Back Healthcare for Future Generations

Big Pharma Likes Big Trials, Biotech CEO Says; Tufts Defends R&D Estimate

Large pharmaceutical companies are comfortable with high R&D costs because they create a barrier to entry in the industry, Cancer Therapeutics, Inc. CEO Robert Oldham, MD, maintained during a Capitol Hill briefing sponsored by the Manhattan Institute June 3

Related Content

UsernamePublicRestriction

Register

PS038971

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel